About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Metabolomics of Insomnia-Related Hyperarousal

NCT01957111·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Pennsylvania

With

Merck Sharp & Dohme LLC

Age

25–55

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Criteria for primary insomnia:
subjective complaint of difficulty initiating or maintaining sleep, waking up too early or nonrestorative sleep
daytime consequences as a result of the poor sleep
duration of at least 1 month
sleep disturbance is not secondary to a medical or psychiatric condition
Criteria for good sleepers:
subjective report of consistent good sleep

You may not be if

significant medical or psychiatric illness
diagnosis of a sleep disorder other than insomnia
women who have been pregnant or lactating in the past 6 months
non-fluency in spoken or written English
Current shift work defined as working during the evening or night shift
Current use of medications that affect sleep
BMI \>27

The record

StatusCompleted

PhaseNo phase

Taking part32

StartedOct 2013

UpdatedJan 11, 2017

Conditions

Primary Insomnia

Where1

University of Pennsylvania
Philadelphia, Pennsylvania, United States

Clareo Health | Metabolomics of Insomnia-Related Hyperarousal